Penn researchers find potential in yeast for selecting Lou Gehrig's disease drugsApril 18, 2008PHILADELPHIA - Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, using yeast cells. In recent months a number of mutations have been found in a disease protein called TDP-43, which is implicated in ALS and certain types of frontotemporal dementia (FTD). "We've created a yeast model, the same cells that bakers and brewers use to make bread and beer, to express TDP-43," explains lead author Aaron D. Gitler, PhD, Assistant Professor of Cell and Developmental Biology. "Remarkably, this protein formed clumps in our simple yeast cells just like it does in human nerve cells. In our paper we determine which segments of the mutated TDP-43 protein cause it to aggregate and which parts cause it to be toxic." Gitler and colleagues report their findings in this week's advance online issue of the Proceedings of the National Academy of Sciences. Two years ago, other Penn investigators found that TDP-43 accumulated abnormally in post-mortem brain or nervous system tissue from individuals diagnosed with either ALS or FTD. TDP-43 is normally involved in RNA and DNA processing, among other cellular tasks. The recent TDP-43 mutation studies confirm the protein's role in causing disease.
The clumping process of proteins takes decades in humans but the researchers could model the process within a matter of hours in yeast cells. This now allows for rapid genetic screening to identify proteins that can reverse the harmful effects of the disease protein; visualizing the clumping; and testing molecules that could eliminate or prevent clumping. "Our yeast model will be a powerful tool for performing large-scale drug screens to look for small molecules that can prevent TDP-43 from aggregating or that can protect cells from aggregated TDP-43," notes Gitler. Normally, TDP-43 stays in the nucleus, but in ALS and FTD it somehow gets sequestered into the cell's cytoplasm, where it forms clumps. "When we put TDP-43 in yeast cells at normal human levels, it remained in the nucleus," explains Gitler. "However, when it was expressed at higher levels, thereby overwhelming the quality control systems of the cell, TDP-43 clumped in the cytoplasm. At even higher levels, TDP-43 became toxic to the yeast cells, making them unable to grow." This experiment suggests, for the first time, that TDP-43 clumps can be a direct cause of cell toxicity. In earlier studies at Penn, researchers found fragments of TDP-43 that were abundant in the clumps found in the post-mortem tissue of ALS and FTD patients. Knowing this, Gitler and colleagues chopped TDP-43 into many fragments to find the segments that are responsible for clumping and toxicity. They found a very similar segment that was also toxic to yeast cells. Designs of future drugs will depend on what part of the TDP-43 protein needs to be disabled. The researchers are able to overexpress every yeast gene to determine which genes can rescue the yeast cells from the TDP-43 toxicity. In addition to these genetic screens, Gitler and colleagues are pursuing drug screens with their TDP-43 model. "We can screen hundreds of thousands of small molecules to see which can get into a yeast cell and prevent TDP-43 from being toxic," says Gitler. "Then we can take the hits we find and test them in animal models. We have already made mutations identical to what have been found in patients and have introduced those in the yeast model." University of Pennsylvania School of Medicine | |||||||||||||||||||||
|
Related Yeast Cells Current Events and Yeast Cells News Articles Catching the blood cell bus gives fatal yeast infection a clean getaway Yeast fungus cells that kill thousands of AIDS patients every year escape detection by our bodies' defences by hiding inside our own defence cells, and hitch a ride through our systems before attacking and spreading, scientists heard today (Tuesday 9 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin. Study shows how daughter is different from mother The mother-daughter relationship can be difficult to understand. Why are the two so different? Now a Northwestern University study shows how this happens. In yeast cells, that is. Scripps research team unravels new cellular repair mechanism The cell cycle, which allows cells to replicate their DNA and produce new cells, is controlled by a complex concert of enzymes and other components. In addition there are "checkpoint" mechanisms that can block continuation of the process if something goes amiss. How small molecule can take apart Alzheimer's disease protein fibers Researchers from the University of Pennsylvania School of Medicine have shown, in unprecedented detail, how a small molecule is able to selectively take apart abnormally folded protein fibers connected to Alzheimer's disease and prion diseases. Genetic 'tag team' keeps cells on cycle By surveying the activity of thousands of genes at several different time points, researchers at the Duke Institute for Genome Sciences & Policy have uncovered new evidence that a network of influential genes act as a kind of genetic tag team to orchestrate one of the most fundamental aspects of all life: the cell cycle. Yeast gives rise to new concept: cell fuel is 'brains' behind division With the cost of diesel and gasoline getting nearer to the hourly minimum wage, too bad the fuel doesn't do more work - like deciding what route to take and pressing the gas pedal. Researchers uncover details about how dietary restriction slows down aging University of Washington scientists have uncovered details about the mechanisms through which dietary restriction slows the aging process. CSHL scientists discover new details of a gene-regulatory network governing metabolism Metabolism is a central feature of life - a myriad of biochemical processes that, together, enable organisms to nourish and sustain themselves. Scientists at Cold Spring Harbor Laboratory (CSHL) are in the forefront of efforts to demonstrate how the regulation of genes governs fundamental life processes, including metabolism. MIT applies engineering approach to studying biological pathways An MIT team has used an engineering approach to show that complex biological systems can be studied with simple models developed by measuring what goes into and out of the system. Diet and lifestyle critical to recovery, says study Diet and lifestyle may play a much more significant role in a person's ability to respond favourably to certain drugs, including some cancer therapies, than previously understood, say scientists. More Yeast Cells Current Events and Yeast Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||